Kunhua Dong

Title: Kunhua Dong: Innovator in Pharmaceutical Chemistry

Introduction

Kunhua Dong is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative treatments for various diseases.

Latest Patents

Kunhua Dong holds a patent for a process related to the manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide. This invention pertains to solid forms of certain N-(pyrimidinyloxy)acrylamide derivatives that are useful in treating proliferation and immunological disorders, as well as other diseases linked to the dysregulation of kinases, including EGFR, Alk, PDGFR, and others. The patent outlines methods for producing these materials, their salts and polymorphs, and pharmaceutical compositions that include them. These solid forms and compositions are beneficial for treating conditions such as tumors, inflammatory diseases, autoimmune diseases, psoriasis, dry eye, rheumatoid arthritis, and lupus.

Career Highlights

Kunhua Dong is currently associated with Acea Therapeutics, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health issues.

Collaborations

He collaborates with talented professionals in his field, including Long Mao and Jia Liu, to enhance the impact of his research and innovations.

Conclusion

Kunhua Dong's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to improving healthcare through scientific advancements. His work continues to pave the way for new treatments that can significantly benefit patients worldwide.